HLA-B*51 and Behçet Disease

REFERENCES

• Behcet H. Über rezidiverende, apthöse durch ein Virus verursachte Geschwuüre am Mund, am Auge und an der Genitalen. Dermatol Wochenschr. 1937; 105: 1152–1157.
   Google Scholar
• Sezer N. Further investigations on the virus of Behcet’s disease. Am J Ophthalmol. 1956; 41(1): 41–55.
   Google Scholar
• Tanaka K, Kajiyama K, Imamura T, et al. Genetic and environmental factors in the development of Behcet’s disease. Tohoku J Exp Med. 1985; 145(2): 205–213.
   Google Scholar
• Studd M, McCance DJ, Lehner T. Detection of HSV-1 DNA in patients with Behcet’s syndrome and in patients with recurrent oral ulcers by the polymerase chain reaction. J Med Microbiol. 1991; 34(1): 39–43.
   Google Scholar
• Lehner T, Lavery E, Smith R, et al. Association between the 65-kilodalton heat shock protein, Streptococcus sanguis, and the corresponding antibodies in Behcet’s syndrome. Infect Immun. 1991; 59(4): 1434–1441.
   PubMedGoogle Scholar
• Kaneko F, Oyama N, Yanagihori H, et al. The role of streptococcal hypersensitivity in the pathogenesis of Behcet’s disease. Eur J Dermatol. 2008; 18(5): 489–498.
   Google Scholar
• Gul A. Behcet’s disease: an update on the pathogenesis. Clin Exp Rheumatol. 2001; 19(5 Suppl 24): S6–S12.
   Web of Science ®Google Scholar
• Zierhut M, Mizuki N, Ohno S, et al. Immunology and functional genomics of Behcet’s disease. Cell Mol Life Sci. 2003; 60(9): 1903–1922.
   PubMed Web of Science ®Google Scholar
• Gul A, Inanc M, Ocal L, et al. Familial aggregation of Behcet’s disease in Turkey. Ann Rheum Dis. 2000; 59(8): 622–625.
   Google Scholar
• Fietta P. Behcet’s disease: familial clustering and immunogenetics. Clin Exp Rheumatol. 2005; 23(4 Suppl 38): S96–S105.
   Google Scholar
• Kone-Paut I, Geisler I, Wechsler B, et al. Familial aggregation in Behcet’s disease: high frequency in siblings and parents of pediatric probands. J Pediatr. 1999; 135(1): 89–93.
   Google Scholar
• Molinari N, Kone Paut I, Manna R, et al. Identification of an autosomal recessive mode of inheritance in paediatric Behcet’s families by segregation analysis. Am J Med Genet A. 2003; 122A(2): 115–118.
   Google Scholar
• Ono S, Aoki K, Sugiura S, et al. Letter: HL-A5 and Behcet’s disease. Lancet. 1973; 2(7842): 1383–1384.
   Google Scholar
• Ohno S, Ohguchi M, Hirose S, et al. Close association of HLA-Bw51 with Behcet’s disease. Arch Ophthalmol. 1982; 100(9): 1455–1458.
   Google Scholar
• Remmers EF, Cosan F, Kirino Y, et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet’s disease. Nat Genet. 2010; 42(8): 698–702.
   Google Scholar
• Mizuki N, Meguro A, Ota M, et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet’s disease susceptibility loci. Nat Genet. 2010; 42(8): 703–706.
   Google Scholar
• de Menthon M, Lavalley MP, Maldini C, et al. HLA-B51/B5 and the risk of Behcet’s disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum. 2009; 61(10): 1287–1296.
   Google Scholar
• Haim S, Gideoni O, Barzilai A. The histocompatibility antigens in patients with Behcet’s disease. Acta Derm Venereol. 1977; 57(3): 243–245.
   Google Scholar
• Yazici H, Akokan G, Yalcin B, et al. The high prevalence of HLA-B5 in Behcet’s disease. Clin Exp Immunol. 1977; 30(2): 259–261.
   Google Scholar
• Lehner T, Batchelor JR, Challacombe SJ, et al. An immunogenetic basis for the tissue involvement in Behcet’s syndrome. Immunology. 1979; 37(4): 895–900.
   Google Scholar
• Schwartz BD, Luehrman LK, Lee J, et al. A public antigenic determinant in the HLA-B5 cross-reacting group—a basis for cross-reactivity and a possible link with Behcet’s disease. Hum Immunol. 1980; 1(1): 37–54.
   Google Scholar
• Muftuoglu AU, Yazici H, Yurdakul S, et al. Behcet’s disease: lack of correlation of clinical manifestations with HLA antigens. Tissue Antigens. 1981; 17(2): 226–230.
   Google Scholar
• Lavalle C, Alarcon-Segovia D, Del Giudice-Knipping JA, et al. Association of Behcet’s syndrome with HLA-B5 in the Mexican mestizo population. J Rheumatol. 1981; 8(2): 325–327.
   Google Scholar
• de Souza-Ramalho P, D’Almeida MF, Freitas JP, et al. Behcet’s disease in Portugal. Acta Med Port. 1991; 4(2): 79–82.
   Google Scholar
• Mizuki N, Ohno S, Ando H, et al. A strong association between HLA-B*5101 and Behcet’s disease in Greek patients. Tissue Antigens. 1997; 50(1): 57–60.
   PubMedGoogle Scholar
• al-Dalaan AN, al Balaa SR, el Ramahi K, et al. Behcet’s disease in Saudi Arabia. J Rheumatol. 1994; 21(4): 658–661.
   Google Scholar
• Kera J, Mizuki N, Ota M, et al. Significant associations of HLA-B*5101 and B*5108, and lack of association of class II alleles with Behcet’s disease in Italian patients. Tissue Antigens. 1999; 54(6): 565–571.
   PubMedGoogle Scholar
• Park SH, Park KS, Seo YI, et al. Association of MICA polymorphism with HLA-B51 and disease severity in Korean patients with Behcet’s disease. J Korean Med Sci. 2002; 17(3): 366–370.
   Google Scholar
• Davatchi F, Shahram F, Chams-Davatchi C, et al. Behcet’s disease in Iran: analysis of 6500 cases. Int J Rheum Dis. 2010; 13(4): 367–373.
   PubMed Web of Science ®Google Scholar
• Kilmartin DJ, Finch A,Acheson RW. Primary association of HLA-B51 with Behcet’s disease in Ireland. Br J Ophthalmol. 1997; 81(8): 649–653.
   Google Scholar
• Ambresin A, Tran T, Spertini F, et al. Behcet’s disease in Western Switzerland: epidemiology and analysis of ocular involvement. Ocul Immunol Inflamm. 2002; 10(1): 53–63.
   Google Scholar
• Pipitone N, Boiardi L, Olivieri I, et al. Clinical manifestations of Behcet’s disease in 137 Italian patients: results of a multicenter study. Clin Exp Rheumatol. 2004; 22(6 Suppl 36): S46–51.
   Google Scholar
• Bettencourt A, Pereira C, Carvalho L, et al. New insights of HLA class I association to Behcet’s disease in Portuguese patients. Tissue Antigens. 2008; 72(4): 379–382.
   Google Scholar
• Meguro A, Inoko H, Ota M, et al. Genetics of Behcet disease inside and outside the MHC. Ann Rheum Dis. 2010; 69(4): 747–754.
   Google Scholar
• Sobao Y, Miwa K,Takiguchi M. The role of the amino acids associated with the HLA-Bw4/Bw6 epitope in peptide binding to HLA-B5, B35 CREG molecules. Immunogenetics. 1999; 49(9): 819–822.
   Google Scholar
• Falk K, Rotzschke O, Takiguchi M, et al. Peptide motifs of HLA-B51, -B52 and -B78 molecules, and implications for Behcet’s disease. Int Immunol. 1995; 7(2): 223–228.
   Google Scholar
• Arber N, Klein T, Meiner Z, et al. Close association of HLA-B51 and B52 in Israeli patients with Behcet’s syndrome. Ann Rheum Dis. 1991; 50(6): 351–353.
   Google Scholar
• Paul M, Klein T, Krause I, et al. Allelic distribution of HLA-B*5 in HLA-B5-positive Israeli patients with Behcet’s disease. Tissue Antigens. 2001; 58(3): 185–186.
   Google Scholar
• Sugisaki K, Saito R, Takagi T, et al. HLA-B52-positive vasculo-Behcet disease: usefulness of magnetic resonance angiography, ultrasound study, and computed tomographic angiography for the early evaluation of multiarterial lesions. Mod Rheumatol. 2005; 15(1): 56–61.
   Google Scholar
• Kikuchi A, Sakaguchi T, Miwa K, et al. Binding of nonamer peptides to three HLA-B51 molecules which differ by a single amino acid substitution in the A-pocket. Immunogenetics. 1996; 43(5): 268–276.
   Google Scholar
• Sakaguchi T, Ibe M, Miwa K, et al. Binding of 8-mer to 11-mer peptides carrying the anchor residues to slow assembling HLA class I molecules (HLA-B*5101). Immunogenetics. 1997; 45(4): 259–265.
   Google Scholar
• Sakaguchi T, Ibe M, Miwa K, et al. Predominant role of N-terminal residue of nonamer peptides in their binding to HLA-B* 5101 molecules. Immunogenetics. 1997; 46(3): 245–248.
   Google Scholar
• Gebreselassie D, Spiegel H,Vukmanovic S. Sampling of major histocompatibility complex class I-associated peptidome suggests relatively looser global association of HLA-B*5101 with peptides. Hum Immunol. 2006; 67(11): 894–906.
   Google Scholar
• Mizuki N, Inoko H, Ando H, et al. Behcet’s disease associated with one of the HLA-B51 subantigens, HLA-B* 5101. Am J Ophthalmol. 1993; 116(4): 406–409.
   Google Scholar
• Gonzalez-Escribano MF, Rodriguez MR, Walter K, et al. Association of HLA-B51 subtypes and Behcet’s disease in Spain. Tissue Antigens. 1998; 52(1): 78–80.
   Google Scholar
• Yabuki K, Ohno S, Mizuki N, et al. HLA class I and II typing of the patients with Behcet’s disease in Saudi Arabia. Tissue Antigens. 1999; 54(3): 273–277.
   Google Scholar
• Kotter I, Gunaydin I, Stubiger N, et al. Comparative analysis of the association of HLA-B*51 suballeles with Behcet’s disease in patients of German and Turkish origin. Tissue Antigens. 2001; 58(3): 166–170.
   Google Scholar
• Mizuki N, Ota M, Katsuyama Y, et al. Sequencing-based typing of HLA-B*51 alleles and the significant association of HLA-B*5101 and -B*5108 with Behcet’s disease in Greek patients. Tissue Antigens. 2002; 59(2): 118–121.
   Google Scholar
• Pirim I, Atasoy M, Ikbal M, et al. HLA class I and class II genotyping in patients with Behcet’s disease: a regional study of eastern part of Turkey. Tissue Antigens. 2004; 64(3): 293–297.
   Google Scholar
• Verity DH, Marr JE, Ohno S, et al. Behcet’s disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens. 1999; 54(3): 213–220.
   PubMedGoogle Scholar
• Yasuoka H, Yamaguchi Y, Mizuki N, et al. Preferential activation of circulating CD8+ and gammadelta T cells in patients with active Behcet’s disease and HLA-B51. Clin Exp Rheumatol. 2008; 26(4 Suppl 50): S59–S63.
   Google Scholar
• Yasuoka H, Okazaki Y, Kawakami Y, et al. Autoreactive CD8+ cytotoxic T lymphocytes to major histocompatibility complex class I chain-related gene A in patients with Behcet’s disease. Arthritis Rheum. 2004; 50(11): 3658–3662.
   Google Scholar
• Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol. 2005; 5(3): 201–214.
   Google Scholar
• Gul A, Uyar FA, Inanc M, et al. A weak association of HLA-B*2702 with Behcet’s disease. Genes Immun. 2002; 3(6): 368–372.
   Google Scholar
• Middleton D, Meenagh A, Sleator C, et al. No association of KIR genes with Behcet’s disease. Tissue Antigens. 2007; 70(5): 435–438.
   Google Scholar
• Duymaz-Tozkir J UF, Saruhan-Direskeneli G, Gul A. KIR3DL1 homozygosity increases the susceptibility to Behcet’s disease in HLA-BW4 positive individuals. Ann Rheum Dis. 2005; 64(July 2005 Suppl 3): 122–123.
   Google Scholar
• Brackenridge S, Evans EJ, Toebes M, et al. An early HIV mutation within an HLA-B*57-restricted T cell epitope abrogates binding to the killer inhibitory receptor 3DL1. J Virol. 2011; 85(11): 5415–5422.
   Google Scholar
• Yoshinoya S, Pope RM. Detection of immune complexes in acute rheumatic fever and their relationship to HLA-B5. J Clin Invest. 1980; 65(1): 136–145.
   Google Scholar
• Zhang Y, Peng Y, Yan H, et al. Multilayered defense in HLA-B51-associated HIV viral control. J Immunol. 2011; 187(2): 684–691.
   Google Scholar
• Maenaka K, Maenaka T, Tomiyama H, et al. Nonstandard peptide binding revealed by crystal structures of HLA-B*5101 complexed with HIV immunodominant epitopes. J Immunol. 2000; 165(6): 3260–3267.
   Google Scholar
• Gur M, Gul, A., Erman, B. Dynamic and static differences between confirmations of HLA-B51 and HLA-B52 may explain the pathogenic mechanism of HLA-B51 in Behcet’s disease. Ann Rheum Dis. 2011; 70(Suppl 3): 209.
   Google Scholar
• Turner MJ, Delay ML, Bai S, et al. HLA-B27 up-regulation causes accumulation of misfolded heavy chains and correlates with the magnitude of the unfolded protein response in transgenic rats: Implications for the pathogenesis of spondylarthritis-like disease. Arthritis Rheum. 2007; 56(1): 215–223.
   Google Scholar
• Colbert RA, DeLay ML, Klenk EI, et al. From HLA-B27 to spondyloarthritis: a journey through the ER. Immunol Rev. 2010; 233(1): 181–202.
   Google Scholar
• Wildner G,Thurau SR. Cross-reactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide: a clue to major histocompatibility complex association with autoimmune disease. Eur J Immunol. 1994; 24(11): 2579–2585.
   Google Scholar
• Kurhan-Yavuz S, Direskeneli H, Bozkurt N, et al. Anti-MHC autoimmunity in Behcet’s disease: T cell responses to an HLA-B-derived peptide cross-reactive with retinal-S antigen in patients with uveitis. Clin Exp Immunol. 2000; 120(1): 162–166.
   Google Scholar
• Takeno M, Kariyone A, Yamashita N, et al. Excessive function of peripheral blood neutrophils from patients with Behcet’s disease and from HLA-B51 transgenic mice. Arthritis Rheum. 1995; 38(3): 426–433.
   Google Scholar
• Sensi A, Gavioli R, Spisani S, et al. HLA B51 antigen associated with neutrophil hyper-reactivity. Dis Markers. 1991; 9(6): 327–331.
   Google Scholar
• Chajek-Shaul T, Pisanty S, Knobler H, et al. HLA-B51 may serve as an immunogenetic marker for a subgroup of patients with Behcet’s syndrome. Am J Med. 1987; 83(4): 666–672.
   Google Scholar
• Taurog JD, Maika SD, Satumtira N, et al. Inflammatory disease in HLA-B27 transgenic rats. Immunol Rev. 1999; 169: 209–223.
   PubMed Web of Science ®Google Scholar
• Kingsbury DJ, Mear JP, Witte DP, et al. Development of spontaneous arthritis in beta2-microglobulin-deficient mice without expression of HLA-B27: association with deficiency of endogenous major histocompatibility complex class I expression. Arthritis Rheum. 2000; 43(10): 2290–2296.
   Google Scholar
• Traherne JA, Horton R, Roberts AN, et al. Genetic analysis of completely sequenced disease-associated MHC haplotypes identifies shuffling of segments in recent human history. PLoS Genet. 2006; 2(1): e9.
   Google Scholar
• Mizuki N, Ota M, Kimura M, et al. Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behcet disease. Proc Natl Acad Sci U S A. 1997; 94(4): 1298–1303.
   Google Scholar
• Ota M, Mizuki N, Katsuyama Y, et al. The critical region for Behcet disease in the human major histocompatibility complex is reduced to a 46-kb segment centromeric of HLA-B, by association analysis using refined microsatellite mapping. Am J Hum Genet. 1999; 64(5): 1406–1410.
   Google Scholar
• Wallace GR, Verity DH, Delamaine LJ, et al. MIC-A allele profiles and HLA class I associations in Behcet’s disease. Immunogenetics. 1999; 49(7–8): 613–617.
   Google Scholar
• Hughes EH, Collins RW, Kondeatis E, et al. Associations of major histocompatibility complex class I chain-related molecule polymorphisms with Behcet’s disease in Caucasian patients. Tissue Antigens. 2005; 66(3): 195–199.
   Google Scholar
• Mizuki N, Meguro A, Tohnai I, et al. Association of major histocompatibility complex class I chain-related gene A and HLA-B alleles with Behcet’s disease in Turkey. Jpn J Ophthalmol. 2007; 51(6): 431–436.
   Google Scholar
• Mizuki N, Ota M, Yabuki K, et al. Localization of the pathogenic gene of Behcet’s disease by microsatellite analysis of three different populations. Invest Ophthalmol Vis Sci. 2000; 41(12): 3702–3708.
   Google Scholar
• Mizuki N, Ohno S, Ando H, et al. HLA-C genotyping of patient with Behcet’s disease in the Japanese population. Hum Immunol. 1996; 50(1): 47–53.
   Google Scholar
• Sanz L, Gonzalez-Escribano F, de Pablo R, et al. HLA-Cw*1602: a new susceptibility marker of Behcet’s disease in southern Spain. Tissue Antigens. 1998; 51(1): 111–114.
   Google Scholar
• Bettens F, Nicoloso de Faveri G,Tiercy JM. HLA-B51 and haplotypic diversity of B-Cw associations: implications for matching in unrelated hematopoietic stem cell transplantation. Tissue Antigens. 2009; 73(4): 316–325.
   Google Scholar
• Park KS, Park JS, Nam JH, et al. HLA-E*0101 and HLA-G*010101 reduce the risk of Behcet’s disease. Tissue Antigens. 2007; 69(2): 139–144.
   Google Scholar
• Seo J, Park JS, Nam JH, et al. Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet’s disease. Tissue Antigens. 2007; 70(4): 307–313.
   Google Scholar
• Chung YM, Yeh TS, Sheu MM, et al. [Behcet’s disease with ocular involvement in Taiwan: a joint survey of six major ophthalmological departments]. J Formos Med Assoc. 1990; 89(5): 413–417.
   PubMedGoogle Scholar
• Kang EH, Kim JY, Takeuchi F, et al. Associations between the HLA-A polymorphism and the clinical manifestations of Behcet’s disease. Arthritis Res Ther. 2011; 13(2): R49.
   Google Scholar
• Kurata R, Nakaoka H, Tajima A, et al. TRIM39 and RNF39 are associated with Behçet’s disease independently of HLA-B*51 and -A*26. Biochem Biophys Res Commun. 2010; 401: 533–537.
   Google Scholar
• Saruhan-Direskeneli G, Uyar FA, Cefle A, et al. Expression of KIR and C-type lectin receptors in Behcet’s disease. Rheumatology (Oxford). 2004; 43(4): 423–427.
   Google Scholar
• Gul A, Uyar FA, Inanc M, et al. Lack of association of HLA-B*51 with a severe disease course in Behcet’s disease. Rheumatology (Oxford). 2001; 40(6): 668–672.
   Google Scholar
• Rudwaleit M. New approaches to diagnosis and classification of axial and peripheral spondyloarthritis. Curr Opin Rheumatol. 2010; 22(4): 375–380.
   Google Scholar
• Nishiyama M, Nakae K, Kuriyama T, et al. A study among related pairs of Japanese patients with familial Behcet’s disease: group comparisons by interval of disease onsets. J Rheumatol. 2002; 29(4): 743–747.
   Google Scholar
• Rozenbaum M, Boulman N, Slobodin G, et al. Behcet disease in adult Druzes in north Israel: the influence of ethnic origin on disease expression and severity. J Clin Rheumatol. 2007; 13(3): 124–127.
   Google Scholar
• Takeuchi M, Hokama H, Tsukahara R, et al. Risk and prognostic factors of poor visual outcome in Behcet’s disease with ocular involvement. Graefes Arch Clin Exp Ophthalmol. 2005; 243(11): 1147–1152.
   PubMed Web of Science ®Google Scholar